ALGS vs CLOV
Aligos Therapeutics Inc (ALGS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ALGS currently screens at market cap $44.1M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ALGS and CLOV stock pages for the full models.
Not investment advice.